- Dexcom RCT suggests CGM benefits for broad diabetes populationIn this edition of STAT Health Tech: Dexcom's CGM trial, udpates from Apple's annual developers' conference, and wearables.STAT · 1mo ago↗ source
- GSK boosts cancer pipeline with $11B Nuvalent buyout<figure><div><img src="https://imgproxy.divecdn.com/mDk-h3NLB8udDPFuDlI7IPou1i9tJKJYucQXUnhK9vA/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTc3MzEzMjc4LmpwZ…BioPharma Dive · 1mo ago↗ source
- STAT+: NIH staffers published a letter of dissent a year ago. They feel it’s been ignoredIn a report published on the first anniversary of the Bethesda Declaration, 71 staffers write that they feel NIH leadership “largely ignored" their concerns.STAT